Average Co-Inventor Count = 6.31
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (5 from 212 patents)
2. Merck Frosst Canada & Co. (4 from 76 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Merck Canada Inc. (2 from 40 patents)
5. Merck Forsst Canada & Co. (1 from 1 patent)
12 patents:
1. 9487504 - Imidazolyl analogs as syk inhibitors
2. 9376418 - Substituted pyridine spleen tyrosine kinase (SYK) inhibitors
3. 8969394 - Thiophenecarboxamide derivatives as EP4 receptor ligands
4. 7553973 - Pharmaceutical compounds
5. 7439260 - 7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
6. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors
7. 6399636 - Tri-aryl-substituted-ethane PDE4 inhibitors
8. 6204275 - PDE IV inhibiting compounds, compositions and methods of treatment
9. 6200993 - Heterosubstituted pyridine derivatives as PDE4 inhibitors
10. 5710170 - Tri-aryl ethane derivatives as PDE IV inhibitors
11. 5410054 - Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
12. 5334597 - Indole carbamates as leukotriene antagonists